Research Analysts' Updated EPS Estimates for August 7th (ACHL, ACIU, ACMR, ACVA, ADTN, ADV, ALEC, ALLO, ALNY, ALVR)
Research Analysts’ updated eps estimates for Monday, August 7th: Achilles Therapeutics (NASDAQ:ACHL) had its buy rating reaffirmed by analysts at Chardan Capital. The firm currently has a $11.00 price target on the stock. AC Immune (NASDAQ:ACIU) had its buy rating reaffirmed by analysts at HC Wainwright. They currently have a $16.00 price target on the […]